6 hasil
Menampilkan 1–6 · 0,14 detik · RSS
Open Forum Infectious Diseases
Scopus
ISSN 2328-8957 · Oxford University Press · 6 artikel di indeks
-
Artikel Jurnal Teks lengkap
Monkeypox: A Contemporary Review for Healthcare Professionals
The ongoing 2022 multicountry outbreak of monkeypox is the largest in history to occur outside of Africa. Monkeypox is an emerging zoonotic disease that for decades has been viewed as an infectious disease with significant epidemic potential because of the increasing occurrence of human outbreaks…
-
Artikel Jurnal Teks lengkap
Long COVID and Post-infective Fatigue Syndrome: A Review
Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed "long-COVID"), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI)…
-
Artikel Jurnal Teks lengkap
Coronavirus Disease 2019 Treatment: A Review of Early and Emerging Options
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spread across the globe resulting in a pandemic. At the time of this review, COVID-19 has been diagnosed in more than 200 000 patients and associated with over 8000 deaths (Centers…
-
Artikel Jurnal Teks lengkap
Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States
BACKGROUND: Due to increasing multidrug-resistant (MDR) infections, there is an interest in assessing the use of bacteriophage therapy (BT) as an antibiotic alternative. After the first successful case of intravenous BT to treat a systemic MDR infection at our institution in 2017, the Center for…
-
Artikel Jurnal Teks lengkap
C-Reactive Protein Level May Predict the Risk of COVID-19 Aggravation
Abstract Background Clinical findings indicated that a fraction of coronavirus disease 2019 (COVID-19) patients diagnosed as mild early may progress to severe cases. However, it is difficult to distinguish these patients in the early stage. The present study aimed to describe the clinical…
-
Artikel Jurnal Teks lengkap
High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019
The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these…